key: cord-0696939-x20n34yb
authors: Földi, Mária; Farkas, Nelli; Kiss, Szabolcs; Dembrovszky, Fanni; Szakács, Zsolt; Balaskó, Márta; Erőss, Bálint; Hegyi, Péter; Szentesi, Andrea
title: Visceral adiposity elevates the risk of critical condition in COVID‐19: A systematic review and meta‐analysis
date: 2020-12-01
journal: Obesity (Silver Spring)
DOI: 10.1002/oby.23096
sha: 559ded6bc1c46f4e8c66d578e96d2ac72ee38300
doc_id: 696939
cord_uid: x20n34yb

OBJECTIVE: A higher body mass index (BMI) has become acknowledged as one of the important risk factors for developing critical condition in coronavirus disease 2019 (COVID‐19). In addition to BMI, body composition, particularly visceral adiposity, might be an even more accurate measure to stratify patients. Therefore, we aimed to evaluate the association between the distributions of CT‐quantified fat mass and critical condition of patients with COVID‐19. METHODS: A systematic search was conducted in five databases for studies published until 17(th) November 2020. In the meta‐analysis, we calculated pooled mean difference (standardized mean difference; SMD) of visceral fat area (VFA; cm(2)) between patients in intensive care unit (ICU) and general ward, and between patients with and without IMV requirement. RESULTS: Our quantitative synthesis revealed that patients requiring intensive care had higher VFA values (SMD=0.46, 95% CI: 0.20, 0.71, p<0.001) compared to patients on the general ward. Similarly, patients requiring IMV had higher VFA values (SMD=0.38, 95% CI: 0.05, 0.71, p=0.026) compared to patients without IMV requirement. CONCLUSIONS: We found that VFA values were significantly higher in patients with critical condition. Therefore, abdominal adiposity seems to be a risk factor in COVID‐19, and patients with central obesity might need special attention.

With the escalation of the pandemic caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), recognizing risk factors is of utmost importance. Among other risk factors such as age and comorbidities (1, 2), a higher BMI has been acknowledged as a risk factor for developing critical condition in coronavirus disease 2019 in our former analysis and in other articles since then (3) (4) (5) (6) . Since the obesity epidemic is rapidly spreading worldwide, it is vital to accurately identify patients with a higher risk for developing critical condition in COVID-19.

Although BMI is widely used to diagnose obesity (7) , body composition, especially visceral adiposity, might be an even more accurate measure to stratify patients (8) (9) (10) (11) (12) . Therefore, we aimed to evaluate the association between the distributions of CT-quantified fat mass and critical condition of patients with COVID-19.

We report this meta-analysis and systematic review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Statement (13) . 

We selected clinical studies reporting on patients hospitalized with confirmed SARS-CoV-2 infection (based on the WHO case definition) and on the distribution of body fat mass assessed by computed tomography (CT). Studies were included in the meta-analysis if data on the following variables were reported: the number of patients with and without critical condition (defined as the need for invasive mechanical ventilation or admission to intensive care unit), distribution of body fat mass (total adipose tissue, TAT; visceral adipose tissue, VAT; subcutaneous adipose tissue, SAT). The latter parameters could be reported as thickness (mm), area (cm 2 ), or volume (cm 3 ). Abstracts and grey literature (preprints and other non-peer-reviewed material) were excluded from the analysis.

The yield of the search was combined in a reference manager software (EndNote X9; Clarivate Analytics, Philadelphia, PA, USA). After automatic and manual removal of duplicate records, full-texts of all studies Accepted Article were evaluated by two independent review authors. Two review authors decided to include a study in the meta-analysis if they agreed. A third author resolved the disagreements. Reference lists of the included studies were screened for additional eligible articles.

Two independent review authors extracted data into a standardized data collection form (Microsoft Excel 365, Microsoft Corporation). The following data were extracted from each eligible article: first and second authors, publication year, study site, sex, age, the number of patients with and without critical condition; and the means, standard deviations, medians, ranges, and interquartile ranges concerning body fat mass (thickness (mm), area (cm 2 ), and volume (cm 3 ) of TAT, VAT, SAT given). Odds ratios and risk ratios (with the corresponding confidence intervals) relating to the association between body fat mass and critical condition were also extracted. A third party resolved discrepancies. The authors of the eligible articles were not contacted for further information.

Quality of the eligible studies was evaluated by using the QUIPS tool by two independent review authors (14) . Any disagreement was resolved by third-party arbitration.

Cohen's kappa coefficient (κ) was calculated to measure inter-rater reliability during the selection process. We calculated pooled mean difference (standardized mean difference; SMD) for continuous variables because the CT examinations were performed at different vertebral levels among studies. We used random effect model with the DerSimonien-Laird estimation (16) . Statistical heterogeneity was calculated performing the I 2 test, and we also carried out the χ 2 tests to acquire probability values: p<0.1 indicated significant heterogeneity. The interpretation of I 2 was the following: 0% to 40%: not important; 30% to 60%: moderate heterogeneity; 50% to 90%: substantial heterogeneity; 75% to 100%: considerable heterogeneity (17) . If the mean with standard deviation could not be extracted, we estimated them from median, interquartiles, and range using the method of Wan et al (18) .

This article is protected by copyright. All rights reserved

The results of the systematic search and selection are shown in the PRISMA Flowchart ( Figure 1 ). The calculated κ value based on the full-text selection was 1.00, which was interpreted as a perfect agreement.

On completion of the selection, six studies, including data from 560 patients, were eligible. The characteristics of the studies included are summarized in Table 1. Five out of six studies, including 509 patients, reported on ICU admission rate, which ranged between 18.5% and 43.3%. Three studies with 208 patients reported on IMV requirement in the association with body composition metrics. The visceral fat area (VFA; cm 2 ) values ranged between 70.9 cm 2 and 240 cm 2 . The results of the quantitative and qualitative synthesis are shown in Table 1 , Table 2 , and Figure 2 .

Our 

Watanabe et al. found that an increased subcutaneous fat area (SFA) is not associated with a higher risk for ICU admission (19) . Yang et al. did not identify SFA >100 mm 2 as a risk factor for ICU admission (OR=1.06, 95% CI: 0.52, 2.17) (9). However, a high VFA/SFA ratio was found to be associated with an increased risk for ICU admission (OR=2.47, 95% CI = 1.05, 5.98) (9) .

Two studies evaluated total fat area (TFA) in COVID-19 patients. Petersen additional risk for ICU admission and IMV requirement, respectively (11). Another study identified an increased TFA as a risk factor for ICU admission in univariate and age-and sex-adjusted multivariate logistic regression analysis (19) .

This article is protected by copyright. All rights reserved

The overall risk of bias was low to moderate in the studies included. Detailed results of the quality assessment are found in Supporting Information.

Our most important finding is that VFA was higher in patients admitted to the ICU and requiring IMV, which draws attention to the importance of abdominal adiposity in COVID-19. There are several theories proposed to explain how abdominal obesity leads to adverse outcomes in COVID-19.

The malfunction of visceral adipose tissue can impair the immune system by producing different inflammatory substances and adipokines (21) . The unhealthy expansion of adipose tissue is associated with endoplasmic reticulum stress, adipose tissue fibrosis, and localized hypoxia (22) . In turn, it is associated with adipocyte cell death and inflammatory response initiation (23). An increase in monocyte chemoattractant protein-1 in visceral adipose tissue contributes to macrophages' infiltration, predominantly M1 macrophages, which promote inflammation, generate reactive oxygen species, and release proinflammatory cytokines, such as tumor necrosis factor-a and interleukin-6. In contrast, lean adipose tissue contains M2 macrophages predominantly, showing an anti-inflammatory activity. Besides, in obesity, inflammation-inducing leptin release increases, whereas protective adiponectin production declines.

The emerging low-grade chronic inflammation may contribute to the "cytokine storm" in severe COVID-19 cases (24) and increases the vulnerability to infections as well as to metabolic and cardiovascular complications, such as insulin resistance, type 2 diabetes mellitus, microvascular disorders, or progressive atherosclerosis (25) . These diseases are also recognized as risk factors in COVID-19 (1). Angiotensinconverting enzyme 2 receptors are also abundant in adipose tissue, contributing to more severe infection and disease course (26) .

This article is protected by copyright. All rights reserved Moreover, visceral obesity is associated with a complex pro-coagulant and a suppressed fibrinolytic profile (among others, due to extensive endothelial damage, enhanced estrogen, and plasmin activator inhibitor-1 production), which can lead to thrombotic complications in COVID-19 (27) .

Severe abdominal obesity also leads to restrictive ventilator disorders with decreased chest compliance and low respiratory reserve (reduced vital capacity and forced expiratory volume in one second), which may aggravate lung complications in COVID-19 (28) .

In addition to CT-quantified VAT, other indicators of abdominal obesity, such as waist circumference and waist-to-hip ratio, would be worth further investigation since they are easily applicable in routine clinical practice (10, 11, (29) (30) (31) Our study has some limitations. Firstly, this difference mentioned above is difficult to interpret without adjusting for BMI and other risk factors such as age, gender, or comorbidities. Nonetheless, most of the included studies performed multivariate analysis, and they mostly agreed on that visceral adiposity might be an independent risk factor for adverse outcomes. Secondly, we could not perform meta-analyses concerning TAT, SAT, or VAT/TAT and VAT/SAT ratio in the absence of a sufficient number of studies.

However, our qualitative synthesis suggested that SAT does not carry a risk of critical condition. Thirdly, we could only combine those studies in the meta-analysis that evaluated VAT by area, which resulted in the exclusion of a study reporting on visceral adipose tissue thickness (8) . Finally, the small number of included studies remained a limitation.

In summary, we found that VFA values were significantly higher in patients with critical condition. In light of the high prevalence of obesity, this area of research should be further investigated. Besides the distribution of body fat, adipose tissue-related substances as potential pharmacological targets might be worth studying as well. 

This article is protected by copyright. All rights reserved 

The negative impact of comorbidities on the disease course of COVID-19

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Effect of obesity and body mass index on coronavirus disease 2019 severity: A systematic review and meta-analysis

Obesity and mortality of COVID-19. Metaanalysis

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection

Obesity is a risk factor for developing critical condition in COVID-19 patients: A systematic review and meta-analysis

Advanced body composition assessment: from body mass index to body composition profiling

Computed Tomography Highlights Increased Visceral

Adiposity Associated With Critical Illness in COVID-19. Diabetes Care

Visceral adipose tissue in patients with COVID-19: risk stratification for severity. Abdominal Radiology

Body Composition Findings by Computed Tomography in SARS-CoV-2 Patients: Increased Risk of Muscle Wasting in Obesity

The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany

Obesity as a Potential Predictor of Disease

Patients: A Retrospective Study

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

Evaluation of the quality of prognosis studies in systematic reviews

Interrater reliability: the kappa statistic

Meta-analysis in clinical trials

Cochrane Handbook for Systematic Reviews of Interventions version 61

Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range

Visceral fat shows the strongest association with the need of intensive care in patients with COVID-19

Obesity in patients with COVID-19: a systematic review and metaanalysis

Interaction of obesity and infections

The cell biology of fat expansion

Increased adipocyte O2 consumption triggers HIF-1alpha, causing inflammation and insulin resistance in obesity

Obesity and COVID-19: The Two Sides of the Coin

Associations of Chronic Inflammation, Insulin Resistance, and

Severe Obesity With Mortality, Myocardial Infarction, Cancer, and Chronic Pulmonary Disease

Obesity and COVID-19: A Perspective from the European Association for the Study of Obesity on Immunological Perturbations, Therapeutic Challenges, and Opportunities in Obesity

New insights into the role of adipose tissue in thrombosis

Association of Pulmonary Function with Adiposity and Metabolic Abnormalities in Urban Minority Adolescents

Fat mass affects nutritional status of ICU

Epicardial Fat Inflammation in severe COVID-19

Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data